Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,264 | -248,226 | -169,193 | -120,645 | -34,973 |
| Depreciation Amortization | -1,525 | -17,990 | -14,833 | -10,244 | -5,307 |
| Accounts payable and accrued liabilities | 5,044 | -37,032 | -24,370 | -1,198 | -31,926 |
| Other Working Capital | 10,424 | -77,352 | -75,030 | 2,516 | -30,228 |
| Other Operating Activity | 2,366 | 76,679 | 101,088 | 25,997 | 45,135 |
| Operating Cash Flow | $-38,955 | $-303,921 | $-182,338 | $-103,574 | $-57,299 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 23,332 | 139,096 | 161,737 | -500 | 91,560 |
| PPE Investments | -1 | 5,753 | 5,834 | 6,131 | 6,945 |
| Sale Of Investment | 0 | 10,016 | 10,016 | 6,082 | 2,391 |
| Investing Cash Flow | $23,331 | $154,865 | $177,587 | $11,713 | $100,896 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5 | 7,330 | 3,524 | 2,518 | 2,807 |
| Other Financing Activity | 0 | -1,937 | 0 | 0 | 0 |
| Financing Cash Flow | $5 | $5,393 | $3,524 | $2,518 | $2,807 |
| Beginning Cash Position | 74,434 | 218,097 | 218,097 | 218,097 | 218,097 |
| End Cash Position | 58,815 | 74,434 | 216,870 | 128,754 | 264,501 |
| Net Cash Flow | $-15,619 | $-143,663 | $-1,227 | $-89,343 | $46,404 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,955 | -303,921 | -182,338 | -103,574 | -57,299 |
| Capital Expenditure | -1 | -1,247 | -1,166 | -869 | -55 |
| Free Cash Flow | -38,956 | -305,168 | -183,504 | -104,443 | -57,354 |